Patients Reimagining VLU and DFU management: Why speed matters in chr... Chronic wounds, particularly venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), represent a persistent and growing challenge in healthcare.
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.